The Effectiveness of the Amount of Polymethylmethacrylate Used in the Treatment of Lumbar Osteoporotic Compression Fractures

Basit Öğe Kaydı
dc.authorwosidÇevik, Serdar/G-7161-2018
dc.contributor.authorYüksel, Mehmet Onur
dc.contributor.authorÇevik, Serdar
dc.contributor.authorErdoğan, Barış
dc.contributor.authorKatar, Salim
dc.contributor.authorTunçkale, Tamer
dc.contributor.authorÇalışkan, Tezcan
dc.contributor.authorEvran, Şevket
dc.date.accessioned2022-05-11T14:34:49Z
dc.date.available2022-05-11T14:34:49Z
dc.date.issued2020
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Beyin ve Sinir Cerrahisi Ana Bilim Dalı
dc.description.abstractObjective: We aimed to investigate the effectiveness of the amount of polymethylmethacrylate used in pain control and maintenance of long-term vertebra corpus height in patients undergoing percutaneous vertebroplasty due to osteoporotic compression fracture of the lumbar vertebra. Method: A total of 60 patients who underwent unilateral percutaneous vertebroplasty between 2014 and 2019 due to osteoporotic compression fracture of the lumbar vertebrae were included in the study. Patients who received 5 ml and 3 ml cement injection were retrospectively analyzed. Of patients, postoperative visual analogue scale (VAS) score and anterior vertebral height of the patients at 1st-year control were evaluated. Results: In the postoperative period, the mean visual analogue scale score was 2.3 +/- 0.46 in the 5 ml injected group and 2.2 +/- 0.4 in the 3 ml injected group (p5 ml=0.001, p3 ml=0.001). There was a statistically significant decline in pain control in both groups. The mean anterior vertebral height loss (AVHL) in the 5 ml injected group was 31.5 +/- 0.40%, and 32.6 +/- 0.47% in the 3 ml injected group (p5 ml=0.820, p3ml=0.870). There was no statistically significant alteration in both groups. Conclusion: Our results indicate that the 3 ml polymethylmethacrylate injection during the percutaneous vertebroplasty procedure provides adequate pain control and stabilization in patients with lumbar vertebral osteoporotic fracture. Therefore we think that small amount of polymethylmethacrylate (3 ml) is sufficient to avoid undesirable complications in this patient group.
dc.identifier.doi10.5222/BMJ.2020.19483
dc.identifier.endpage335
dc.identifier.issn1305-9319
dc.identifier.issn1305-9327
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85191819776
dc.identifier.scopusqualityQ4
dc.identifier.startpage330
dc.identifier.urihttps://doi.org/10.5222/BMJ.2020.19483
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8102
dc.identifier.volume16
dc.identifier.wosWOS:000609064300004
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorTunçkale, Tamer
dc.institutionauthorÇalışkan, Tezcan
dc.language.isoen
dc.publisherYerkure Tanitim & Yayincilik Hizmetleri A S
dc.relation.ispartofMedical Journal of Bakirkoy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCompression fractures
dc.subjectosteoporotic fractures
dc.subjectpain
dc.subjectpolymethyl methacrylate
dc.subjectspinal fractures
dc.subjectvertebroplasty
dc.subjectvisual analog scale
dc.subjectQuality-Of-Life
dc.subjectPercutaneous Vertebroplasty
dc.subjectCement Volume
dc.subjectPain Relief
dc.subjectKyphoplasty
dc.subjectOutcomes
dc.titleThe Effectiveness of the Amount of Polymethylmethacrylate Used in the Treatment of Lumbar Osteoporotic Compression Fractures
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
8102.pdf
Boyut:
615.75 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu